Contact this trialFirst, we need to learn more about you.
Virus Therapy
FLT201 for Gaucher Disease
Recruiting1 awardPhase 1 & 2
Fairfax, Virginia
This trial will follow participants with Gaucher disease type 1 who were previously treated with FLT201 in a different trial. The participants will be monitored for 5 years after the treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service